Why Does α-Interferon Work in Chronic Granulocytic; Leukaemia?

References

• Cunningham I., Gee T., Dowling M. Results of treatment of Ph+ chronic myelogenous leukaemia with an intensive treatment regimen (L-5 protocol). Blood 1979; 53: 375–395
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjan H. M., McCredie K. B., Keating M. J., Trujillo J., Gutterman J. Clinical investigation of human αinterferon in chronic myeloid leukaemia. Blood 1987; 68: 1280–1288
   Google Scholar
• Strife A., Clarkson B. Biology of chronic myelogenous leukaemia: is discordant maturation the primary defect. Sem. Haem. 1988; 25: 1–19
   PubMed Web of Science ®Google Scholar
• Eaves C. J., Eaves A. C. Cell culture studies in CML. Chronic Myeloid Leukaemia, J. M. Goldman. Balliere Tindall, London 1987; 931–962
   Google Scholar
• Gale R. P. CML: a model for human cancers. Chronic Myeloid Leukaemia, J. M. Goldman. Balliere Tindall, London 1987; 869–886
   Google Scholar
• Galvani D. W. Cytokines: biological function and clinical use. J. Roy. Coll. Phys. 1988; 22: 226–231
   PubMedGoogle Scholar
• Kimchi A. Increased levels of interferon induced 2′5′ oligoadenylate synthetase in mature T lymphocytes and in differentiated friend erythroleukaemic cells. J. Interferon Res. 1981; 1: 559–569
   PubMedGoogle Scholar
• Galvani D. W., Griffiths S., Cawley J. C. Interferon for treatment: the dust settles. Br. Med. J. 1988; 296: 1554–1556
   PubMed Web of Science ®Google Scholar
• Reid L. M., Minato N., Gresser I., Holland J., Kedish A., Bloom B. R. Influence of anti mouse interferon serum on the growth and metastasis of tumour cells persistently infected with virus and of human prostatic tumours in athymic mide mice. Proc. Natl. Acad. Sci. 1981; 78: 1179–1189
   Google Scholar
• Lotzova E., Savary C. A., Keating M. J. Leukaemia diseased patients exhibit multiple defects in natural killer cell lytic machinery. Exp. Haem. 1983; 10: 83–86, Suppl 12
   Google Scholar
• Galvani D. W., Owens W., Nethersell A. B. W., Cawley J. C. The beneficial effects of αIFN in CGL are probably not mediated by NK cells. Br. J. Haem. 1989; 71: 233–237
   PubMed Web of Science ®Google Scholar
• Griffiths S., Cawley J. C. The beneficial effects of αIFN in HCL are not attributable to NK cell mediated cytotoxicity. Leukaemia 1987; 1: 372–376
   PubMed Web of Science ®Google Scholar
• Galvani D. W., Cawley J. C. The beneficial effects of αIFN in CGL are probably not mediated by NK cells. Br. J. Haem. 1989; 71: 169
   Web of Science ®Google Scholar
• Fujimiya Y., Pattengale P. M. Characterisation of NK cells in patients with CML. Mechanisms of Cytotoxicity of NK Cells, R. B. Herberman, D. M. Callewaert, R. B. Herberman, D. M. Callewaert. Academic Press, London 1985; 521–528
   Google Scholar
• Griffiths S. D., Cawley J. C. αInterferon and LAK cell activity in HCL. Leukaemia 1988; 2: 377–381
   PubMedGoogle Scholar
• Pelus L. M., Ottman O. G., Nocka K. H. Synergistic inhibition of human CFU-GM progenitors by prostaglandin E and recombinant IFN-á β and γ and an effect mediated by tumour necrosis factor. J. Immunol. 1988; 140: 479–484
   PubMed Web of Science ®Google Scholar
• Duncombe A. S., Heslop H. E., Turner M., Meager A., Brenner M. K. Autocrine production of TNF inhibits CML growth — a mechanism for chronicity. Br. J. Haem. 1989; 71: 169
   Google Scholar
• Broxmeyer H. E., Lu L., Platzner E., Feit C., Juliano L., Rubin B. Y. Comparative analysis of the influences of human α, β and γIFNs on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 1983; 131: 1300–1305
   PubMed Web of Science ®Google Scholar
• Beran M., McCredie K. B., Keating M. J., Gutterman J. U. Anti-leukaemic effect of recombinant TNF in vitro and its modulation by α and γ IFNs. Blood 1988; 72: 728–738
   PubMed Web of Science ®Google Scholar
• Dowding C., Gordon M. Y., Goldman J. M. Effect of recombinant αIFN on normal and CGL progenitors. Exp. Haem. 1987; 15: 441
   Google Scholar
• Degliantoni G., Perussia B., Mangoni L., Trinchieri G. Inhibition of BM colony formation by human NK cells and by NK cell-derived colony inhibitory activity. J. Exp. Med. 1985; 161: 1152–1168
   PubMed Web of Science ®Google Scholar
• Galvani D. W., Cawley J. C. Mechanism of action of IFN in chronic granulocytic leukaemia; evidence for preferential inhibition of late progenitors. Br. J. Haem. 1989, (submitted)
   Web of Science ®Google Scholar
• Andreeff M. Cell kinetics in leukaemia. Sem. Haem. 1986; 23: 300–314
   Google Scholar
• Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells. in vitro. J. Cell Physiol. 1977; 91: 335–344
   PubMed Web of Science ®Google Scholar
• Rosenblum M. G., Maxwell B. L., Talpaz M., Kellehar P. J., McCredie K. B., Gutterman J. U. In vivo sensitivity and resistance of CML cells to αIFN: correlation with receptor binding and induction of 2′, 5′-oligoadenylate synthetase. Can. Res. 1986; 46: 4848–4852
   PubMed Web of Science ®Google Scholar
• Watson R. B., Nash J. R., Cawley J. C., Galvani D. W. The expression of interferon receptors in normal and neoplastic leukocytes. J. Path. 1988; 155: 340
   Google Scholar
• Cannistra S. A., Herrmann F., Davis R., Nichols K., Griffin J. D. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by Prostaglandin E. J. Clin. Invest. 1986; 77: 13–20
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. F. Altered adhesive interactions with marrow stroma of haemopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342–344
   PubMed Web of Science ®Google Scholar
• Yoffe G., Blick M., Kantarjian H., Spitzer G., Gutterman J., Talpaz M. Molecular analysis of interferon-induced suppression of Ph chromosome in patients with CML. Blood 1987; 69: 961–963
   PubMed Web of Science ®Google Scholar
• Lindeman A., Ludwig W. D., Oster W., Mertelsman R., Herrman F. High level secretion of TNFα contributes to haemopoietic failure in hairy-cell leukaemia. Blood 1989; 73: 880–884
   PubMed Web of Science ®Google Scholar
• Cashman J., Eaves A. C., Eaves C. J. Regulated proliferation of primitive haemopoietic progenitor cells in long term bone-marrow cultures. Blood 1985; 66: 1002–1005
   PubMed Web of Science ®Google Scholar
• Griffiths S. D., Galvani D. W., Cawley J. C. (in press). The Interferons. Immunotherapy of Disease, T. J. Ed: Hamblin. Martin Lister Press, Lancaster
   Google Scholar